Thus, our observation that JNJ greatly lowers the mRNA expression levels of leptin, but not adiponectin, further supports JNJ as a novel therapeutic for the obesity remedy and its related diseases linked with leptin overexpression. The gene discussed is ADIPOQ; the disease is obesity disorder.